By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



9560 Strickland Road
Suite 103-146
Raleigh  North Carolina  27615  U.S.A.
Phone: 919-274-0703 Fax: n/a



Company News
Scioderm To Present Data From Phase 2b Study Of Zorblisa™ (SD-101) At The Debra International Congress 9/9/2014 8:00:41 AM
Scioderm Names Ronald Nardi, Ph.D. Chief Scientific Officer 6/12/2014 7:55:17 AM
Scioderm Receives Orphan Drug Designation In The European Union For Novel Topical Therapy To Treat Epidermolysis Bullosa 1/23/2014 10:49:37 AM
Scioderm To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/7/2014 6:39:28 AM
Scioderm Initiates Phase 2B Study Of SD-101, A Novel Topical Therapy, For Patients With Epidermolysis Bullosa 1/6/2014 8:38:02 AM
Scioderm Receives Positive Opinion From European Orphan Medicinal Products Committee For Novel Topical Therapy To Treat Epidermolysis Bullosa 12/17/2013 10:35:40 AM
Scioderm Appoints Orphan Product Executives To Board Of Directors 12/2/2013 6:45:04 AM
Scioderm Honored With Partners in Progress Award From DEBRA of America 10/30/2013 10:49:21 AM
Scioderm's CEO Dr. Robert Ryan Appointed Member of DebRA Board 10/21/2013 6:32:05 AM
Novella Clinical Selected by Scioderm to Manage Rare Disease Study 10/15/2013 10:03:47 AM